​
Login / Signup
Hanwen Zhu
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 8
Top Topics
Late Onset
Clinical Trial
High Resolution
Tyrosine Kinase
Top Venues
Science (New York, N.Y.)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)
Hanwen Zhu
,
Francesca Tonelli
,
Martin Turk
,
Alan R Prescott
,
Dario R Alessi
,
Ji Sun
Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Science (New York, N.Y.)
382 (6677) (2023)